Pulmonary Function and Neuromuscular Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03445832

Acronym

PREMDEN

Enrollment

Registered

2018-02-26

Start date

2018-01-08

Completion date

2018-02-10

Last updated

2018-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Diseases

Brief summary

This study aims to describe the evolution of pulmonary function in 3 neuromuscular diseases : Duchenne muscular dystrophy, Werdnig-Hoffinann disease, congenital myopathy, monitored in Besançon university hospital.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Years to 17 Years

Healthy volunteers

Inclusion criteria

* Neuromuscular disease * Followed-up in Besançon University Hospital * With at least 2 Pulmonary Function Tests previously performed

Exclusion criteria

* Mental deficiency * Facial expressions disorders

Design outcomes

Primary

Measure	Time frame	Description
FVC (Forced Vital Capacity)	Year 12	Percentage of decrease of FVC sitting or lying down

Countries

France

Outcome results